Search results
Jun 4, 2024 · The estimated Net Worth of Marc Tessier Lavigne is at least $2 Billion dollars as of 23 November 2022. Marc Lavigne owns over 20,000 units of Regeneron Pharmaceuticals stock worth over $1,969,746,718 and over the last 13 years he sold REGN stock worth over $29,555,810.
- Wallmine GB
Wallmine GB - Marc Tessier-Lavigne Net Worth (2024) |...
- Wallmine CA
Wallmine CA - Marc Tessier-Lavigne Net Worth (2024) |...
- Wallmine In
Wallmine In - Marc Tessier-Lavigne Net Worth (2024) |...
- Dr. Marc Tessier-Lavigne Net Worth
As the Co-Founder and Chairman of Scientific Advisory Board...
- Wallmine GB
Jun 1, 2024 · As the Co-Founder and Chairman of Scientific Advisory Board & Independent Director of Denali Therapeutics Inc, the total compensation of Dr Lavigne at Denali Therapeutics Inc is $55,000. There are 18 executives at Denali Therapeutics Inc getting paid more, with Ryan Watts having the highest compensation of $4,978,610.
Nov 23, 2022 · The estimated net worth of Marc Tessier-Lavigne is at least $35.11 million as of November 23rd, 2022. Dr. Tessier-Lavigne owns 1,870,356 shares of Denali Therapeutics stock worth more than $35,106,582 as of December 4th.
- (615) 866-8548
- Director, Denali Therapeutics
- hansen@dnli.com
The estimated net worth of Marc Tessier-lavigne is at least $55 Million dollars as of 2024-06-15. Marc Tessier-lavigne is the Director of Denali Therapeutics Inc and owns about 2,107,225 shares of Denali Therapeutics Inc (DNLI) stock worth over $44 Million.
Oct 3, 2022 · The estimated net worth of Marc Tessier-Lavigne is at least $1.65 billion as of November 23rd, 2022. Dr. Tessier-Lavigne owns 1,870,356 shares of Regeneron Pharmaceuticals stock worth more than $1,649,092,885 as of December 28th.
- (914) 847-7000
- Director, Regeneron Pharmaceuticals
- invest@regeneron.com
May 30, 2024 · Marc Tessier-Lavigne Founder at DENALI THERAPEUTICS INC. Net worth: 39 M $ as of 2024-05-30
Jun 18, 2024 · Marc Tessier-Lavigne has an estimated net worth of $111 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS, INC., PFIZER INC, AGIOS...
